Hemolytic anemia develops when erythropoiesis fails to compensate for the loss from premature destruction of erythrocytes. Several treatment modalities are available depending on the onset and severity of the condition. This article describes various therapeutic approaches for hemolytic anemia. Hemolytic anemia can be inherited or acquired. The severity of the anemia depends on the type of hemolysis onset- gradual or spontaneous- and on the extent of erythrocyte destruction.
Mild hemolysis can be asymptomatic while the anemia in severe hemolysis can be life threatening and cause angina or cardiopulmonary decompensation. Therapeutic Modalities Often the treatment of hemolytic anemia depends on the type of hemolysis. In most cases of hemolytic anemia, prophylactic folic acid is recommended because active hemolysis can consume folate and cause megaloblastosis. Although corticosteroids are…
